Sex (male/female) | 95/81 |
Age (years) | 62 (28–78) |
AST (IU/L) | 43.5 (18–217) |
ALT (IU/L) | 48.0 (11–225) |
Total bilirubin (mg/dL) | 0.8 (0.1–2.7) |
Hemoglobin (g/dL) | 14.5 (10.1–18.3) |
White blood cells (/µL) | 4905 (2100–9610) |
Platelet count (×104/µL) | 15.3 (5.9–28.0) |
HCV RNA (log copies/mL) | 6.5 (5.0–7.8) |
IL28B genotype (SNP8099917) (TT/non-TT) | 69/22 |
HCV Core aa70 (wild/mutant) | 38/13 |
HCV Core aa91 (wild/mutant) | 32/19 |
Treatment-naïve/relapsers/non-responders/unknown | 85/51/26/14 |
Prior therapy (IFN only/IFN + RBV/Peg-IFN/Peg IFN + RBV/teraprevir/Others) | 12/7/5/49/3/12 |
Histological fibrosis (METAVIR score) (F0/F1/F2/F3/F4/ND) | 1/28/34/30/4/79 |